Clinical trial
Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With…
NCT00232739 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00232739 |
|---|---|
| Title | Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions |
| Official title | A Multicenter, Non-Randomized Study of the 2.25mm Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | CYPHER Sirolimus-eluting Coronary Stent |
| Enrollment | 100 |
| Start date | Sep 1, 2003 |
| Primary completion | Nov 1, 2004 |
| Completion | Aug 1, 2009 |
| First posted | Oct 5, 2005 |
| Last update posted | Mar 16, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: